Trials / Completed
CompletedNCT04401163
Long-term Pulmonary Outcomes After Infection With Sars-CoV-2
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 218 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- —
Summary
The objective of this study is to assess the long-term outcomes after hospital admission with Covid-19 with respect to pulmonary function, physical capacity, imaging, quality of life and socioeconomic outcomes.
Detailed description
Patients will be invited to follow-up visits 3 and 12 months after hospitalization with COVID19. Inclusion will take place during 2020. We expect to enroll 180 non-ICU patients and 36 ICU patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Imaging of the lungs | After hospital admissions with COVID19 patients will come for two clinical visits to complete a number of questionnaires, pulmonary function testing, six-minute walk test, blood sampling and imaging of the lungs. |
Timeline
- Start date
- 2020-06-18
- Primary completion
- 2021-10-01
- Completion
- 2022-08-01
- First posted
- 2020-05-26
- Last updated
- 2023-05-12
Locations
6 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04401163. Inclusion in this directory is not an endorsement.